Abstract:Objective To investigate the effectiveness of contrast ultrasound (CEUS) in patient selection, efficacy verification and guidance during ablation treatment of liver cancer. Methods A to-tal of 168 focal liver lesions in 137 patients with liver cancer (131 with HCC, 6 with metastasis liver cancer-MLC) were examined using CEUS before and after ablation treatment. As for the CEUS, the low MI real time imaging technique-CPS and 2.4 ml SonoVue-the 2nd generation of ultrasound con-trast agent by bolus injection through the elbow vein were used. The effectiveness of ablation treat-ment was evaluated by CEUS after the ablation treatment. The results of CECT/CEMRI or biopsy ob-tained at the same stage with CEUS examination were adopted as gold standard. The biopsy diagnosis was obtained for all cases before ablation. Results Completed ablation was achieved in 91.1 % of 137 recruited cases (80 cases received microwave ablation, 57 multi-probe Ethanol ablation-QRA), un-completed ablation was observed in 8. 9 % cases, local recurrence was found in 8.3 % cases. Before ab-lation treatment, significant difference of tumor size pre and post contrast administration were ob-served in 4 patients(2.9%). More tumors were found for 16 cases, less tumor were found for 5 cases with CEUS comparing with un-enhanced US examination. Eight lesions were confirmed by CEUS but cannot be determined by un-enhanced US. There were 29 cases (21.2%) whose observed tumor num-ber was changed after SonoVue administration and the treatment protocol was changed for 12 cases (8.8%)due to the modification of tumor number after CEUS examination. After the ablation treat-ment, residue tumor tissue in 15 cases and local recurrence in 11 cases were confirmed by CEUS, which cannot he observed by no-enhanced US, and the re-ablations were performed under the guidance of CEUS. Meanwhile, there was one local recurrence lesion, and one lesion with residual tumor tissue hadn't been detected by CECT, but were confirmed by CEUS, and verified by biopsy later. Comparing with CECT/or CEMRI, the accuracy of diagnosis of the local recurrence lesion and residual tumor tis-sue after ablation treatment were 98.8 %. Conclusion Before the ablation treatment, CEUS can be helpful for selecting appropriate patients, making reasonable treatment protocol and detecting the tumor which cannot be seen under un-enhanced US. After the ablation treatment, CEUS can define ablation margin, provide accurate judgment for ablation result, sensitively detect the small residual tumor tissue and focal recurrence which cannot be detected by US. Meanwhile, CEUS can be used for guiding the needle when re-treatment is performed for residual tumor or focal recurrence.

The clinical application of contrast enhanced ultrasonography in radiofrequency ablation therapy for residual and recurrent hepatic neoplasms

[Application of Contrast-Enhanced Ultrasonography in Selecting Indication of Radiofrequency Ablation among Hepatocellular Carcinoma Patients].

The role of contrast enhanced ultrasound in radiofrequency ablation of liver metastasis

Radiofrequency ablation of small hepatic malignancies guided by contrast enhanced ultrasonography

Clinical value of contrast enhanced ultrasound for identifying ablation range and designing treatment protocol of radiofrequency ablation in hepatocellular carcinoma

Study on Contrast-enhanced Ultrasound in the Assessment of Local Response to Ablation Therapy for Hepatocellular Carcinoma

Bipolar Radiofrequency Ablation for Liver Tumors: Comparison of Contrast-Enhanced Ultrasound with Contrast-Enhanced MRI/CT in the Posttreatment Imaging Evaluation.

The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.

Contrast-enhanced Ultrasound in the Assessment of Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma

Contrast-enhanced Ultrasound in the Characterization of Hepatocellular Carcinomas Treated by Ablation: Comparison with Contrast-Enhanced Magnetic Resonance Imaging.

Role of Contrast Enhanced Ultrasound in Radiofrequency Ablation of Metastatic Liver Carcinoma

Application value of contrast - enhanced ultrasonography in managing liver metastases before percutaneous radiofrequency ablation treatment

Efficacy of contrast-enhanced ultrasound guided radiofrequency ablation on different sizes hepatocellular carcinoma

Efficacy of Treatment on Liver Metastases by Contrast Enhanced Ultrasonography-Guided Percutaneous Radiofrequency Ablation

Hepatocellular Carcinoma after Ablation: the Imaging Follow-Up Scheme

The Study on Contrast Enhanced Ultrasonography in the Evaluating Therapeutic Response of Hepatic Malignancies Treated with Radiofrequency Ablation

0304: Value of Contrast Enhanced Ultrasound for Protocoling Radiofrequency Ablation of Hepatocellular Carcinoma

Radiofrequency Ablation for Hepatocellular Carcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Guiding and Assessing Early Therapeutic Response and Short-Term Follow-Up Results

Fusion Imaging of Contrast-Enhanced Ultrasound and Contrast-Enhanced CT or MRI Before Radiofrequency Ablation for Liver Cancers

Application of Contrast Ultrasound in Ablation Treatment of Liver Cancer

Clinical value of contrast-enhanced ultrasonography immediately after radiofrequency ablation for malignant hepatic tumors